双能CT物质分解鉴别肝内胆管癌与肝细胞癌
回顾性纳入94例肝内胆管癌或肝细胞癌患者,行动脉期腹部双能CT增强扫描,以病理为参考标准。肝内胆管癌的碘密度、归一化碘摄取、衰减和脂肪分数均显著低于肝细胞癌,其中碘密度鉴别能力最高(AUC=0.93),阈值2.33 mg/dl时敏感度89.4%、特异度76.6%。
要点
- 动脉期碘密度是鉴别肝内胆管癌与肝细胞癌的最优双能CT参数。
- 肝内胆管癌碘密度、归一化碘摄取及衰减均低于肝细胞癌。
- 碘密度阈值2.33 mg/dl时敏感度89.4%、特异度76.6%。
关键影像表现/征象
- 动脉期肝内胆管癌碘密度为1.6±0.5 mg/ml,低于肝细胞癌的2.8±0.8 mg/ml(p<0.001)。
- 肝内胆管癌归一化碘摄取为14.5±4.8,低于肝细胞癌的24.8±10.3(p<0.001)。
- 肝内胆管癌衰减为41.9±10.1 HU,低于肝细胞癌的47.9±8.9 HU(p=0.003)。
- 肝内胆管癌脂肪分数为12.0±7.8%,高于肝细胞癌的9.0±6.4%(p=0.045)。
诊断标准与关键数值
- 碘密度鉴别肝内胆管癌与肝细胞癌的AUC为0.93(95%CI 0.89-0.98)。
- 碘密度最佳阈值为2.33 mg/dl,敏感度89.4%,特异度76.6%。
临床应用与阅片要点
- 动脉期双能CT碘密度可用于辅助鉴别肝内胆管癌与肝细胞癌。
- 阅片时关注碘密度值,低于2.33 mg/dl提示肝内胆管癌可能。
局限性
- 回顾性研究设计。
- 单中心样本量有限(94例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the potential of material decomposition in dual-energy CT (DECT) to differentiate intrahepatic cholangiocarcinoma (iCCA) from hepatocellular carcinoma (HCC).
METHOD: In this retrospective study, we included 94 patients (26 female (27.7 %), median age 64.5 (interquartile range 55.5-74.5) years) with either iCCA or HCC who underwent abdominal contrast-enhanced DECT in arterial phase. To test for differences between iCCA (n = 47) and HCC (n = 47), we evaluated mean attenuation and DECT material density values including iodine density (ID), normalized iodine uptake (NIU), fat fraction, and lesion-to-liver parenchyma ratio. Histopathology served as reference standard for all lesions. We used univariate logistic regression models for the outcome iCCA versus HCC. ROC curve analysis was applied to assess discriminative ability of the model. Model accuracy was evaluated by calculating the Brier score. Youden index was applied to establish thresholds to differentiate between iCCA and HCC.
RESULTS: Comparison of quantitative image parameters revealed significant differences between iCCA and HCC for ID (1.6 ± 0.5 mg/ml vs 2.8 ± 0.8 mg/ml, p < 0.001), NIU (14.5 ± 4.8 vs 24.8 ± 10.3, p < 0.001), attenuation (41.9 ± 10.1 HU vs 47.9 ± 8.9 HU, p = 0.003), and fat fraction (12.0 ± 7.8 % vs 9.0 ± 6.4 %, p = 0.045). ROC curve analysis revealed highest ability to differentiate iCCA from HCC for ID (AUC = 0.93, 95 % CI 0.89-0.98). For ID, an optimal threshold of 2.33 mg/dl was determined to discriminate between iCCA and HCC (sensitivity 89.4 %, specificity 76.6 %).
CONCLUSIONS: DECT-based iodine quantification can serve as a tool for the differentiation of iCCA and HCC in contrast-enhanced CT. ID yielded the highest diagnostic performance and may assist in clinical routine CT diagnostics.
引用
- Mahmoudi, Bernatz, Althoff, et al. Dual-energy CT based material decomposition to differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma. Eur J Radiol. 2022. PMID: 36270195. doi:10.1016/j.ejrad.2022.110556
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。